The global research and development (R&D) ecosystem is expanding rapidly, with $1.7 trillion invested worldwide. R&D now involves universities, companies, philanthropies, and nonprofits, not just governments. Scientific capabilities have advanced through artificial intelligence, open data, and worldwide collaboration, but the supporting systems are under stress.
To discuss these issues, the Karen Toffler Charitable Trust (KTCT) hosted a private Exeloop℠ dinner in Los Angeles on October 22, 2025, bringing together leaders from academia, philanthropy, industry, and government. The conversation focused on sustaining innovation, supporting early-career researchers, and strengthening collaboration in traditional research funding contracts.
A System Under Strain
Attendees began by noting that research now faces more constraints than before. To alleviate these pressures, policymakers should consider targeted funding increases in neuroscience and biomedical research, streamline administrative processes, and reduce compliance burdens to free scientists' time, thereby strengthening the research foundation.
Several participants compared the current system to a body in survival mode. “The research ecosystem right now is fasting,” one guest observed. “Short-term restraint can bring focus, but over time, fasting turns to starvation.”
Without new investment, this 'fasting' will make it harder for young scientists and slow down promising innovations. As grants become harder to obtain, labs cut back, and early-career researchers leave academia, creating long-term consequences for the research ecosystem.
The Collaboration Imperative
Attendees emphasized that closing the 'valley of death' requires concrete industry-academia partnerships, such as joint pilot programs and shared funding initiatives, to accelerate the translation of promising discoveries into clinical and market applications, inspiring stakeholders to support such collaborations.
Participants emphasized the industry’s essential role in scaling discoveries, navigating regulatory pathways, and bringing innovations to market. Strengthening partnerships among academia, philanthropy, and industry can foster a sense of shared purpose and collective impact.
Guests underscored the need to expand patient access to research, to ensure that the benefits of innovation reach communities earlier and more equitably. Direct patient community participation in data sharing, study design, and translational pathways was seen as a lever to accelerate adoption and impact.
Attendees highlighted the need for better intellectual property (IP) support for early-stage technology. Many young researchers lack guidance on IP, licensing, or partnerships. The group agreed that institutions should help investigators secure their work, establish clear agreements, and balance openness with value protection.
Rethinking Philanthropy’s Role
The group spent a lot of time discussing both the potential and the limits of philanthropy.
Guests agreed philanthropy needs to be more flexible and open to experimentation, encouraging a culture of innovation and courage rather than acting like a bureaucracy or funding only safe projects.
One participant summarized it plainly: “Philanthropy needs to dream with science by funding high-risk, high-reward projects, supporting early-stage research, and fostering innovative pilot programs that challenge conventional boundaries.”
Attendees discussed how different types of philanthropy could work together. Institutional donors offer stability, credibility, and long-term support, while venture-style funds are more agile and can respond quickly. A hybrid approach could bring these strengths together, combining stability with the ability to take smart risks.
Philanthropy can help protect early-stage IP. Many young investigators need education to secure discoveries. Grants should provide IP training and legal support, empowering scientists and encouraging collaboration.
Transparency, Trust, and Public Understanding
Another key theme was the need for greater transparency in how research is funded and communicated. Clear pathways for donors to identify promising projects can build trust and confidence among stakeholders and the public.
Participants proposed developing information-matching systems; digital platforms that link donor priorities with researcher proposals in real time while preserving confidentiality.
The conversation also highlighted the need for better public education. Most people do not really understand how research works, including its timelines, costs, risks, and effects on jobs and innovation.
As one guest said, “We can’t expect the public to support what it doesn’t understand.”
By showing how scientific investment creates new jobs, drives economic growth, and improves health, researchers and funders can help rebuild trust. Open communication about both successes and failures will be key to keeping the public engaged.
From Fasting to Flourishing
As the dinner ended, participants looked ahead. Most felt cautiously optimistic. The challenges are real, including funding gaps, slow-moving systems, and public doubt, but the group believed solutions are possible.
Attendees agreed that coherence, aligning policy, funding, and purpose, is the goal. Governments must support basic science, philanthropies should take real risks, researchers should cross disciplines, and companies should see innovation as shared, not just competitive.
The main message: Without investment in people, infrastructure, and teamwork, progress will stall. But if funders, researchers, industry, and the public all step up, the potential is enormous.
Three priorities emerged:
Integration: Ensure that policies, funding streams, technologies, and data systems are actively coordinated among all sectors to strengthen the coherence of the research environment.
Collaboration: Create multi-sector, multidisciplinary teams, including patients, funders, researchers, and industry, so that research benefits from a wide range of expertise and partnerships, resulting in more effective, scalable outcomes.
Imagination: Foster a culture where philanthropists and researchers actively work together to identify and pursue novel and groundbreaking research opportunities.
As the evening concluded, the discussion returned to a shared recognition that innovation cannot flourish in isolation. A research ecosystem built on fragmented funding, siloed institutions, and short-term incentives will continue to underperform, no matter how advanced the science becomes. Participants agreed that the path forward lies in coherence: aligning public investment, philanthropic risk-taking, institutional support, and industry partnership around a common purpose. By integrating systems, deepening collaboration across sectors, and restoring imagination to how research is funded and translated, the community can move from a period of “fasting” to one of sustainable growth, ensuring that scientific discovery continues to advance knowledge, reach patients, and serve the public good.
About the Karen Toffler Charitable Trust
The Karen Toffler Charitable Trust (KTCT) is a 501(c)(3) nonprofit founded by futurists Alvin and Heidi Toffler in memory of their daughter Karen. KTCT supports early-career researchers working on new neuroscience projects and encourages collaboration among academia, industry, and philanthropy. Through programs such as the Toffler Scholars Program and the Exeloop series, KTCT carries on the Tofflers’ legacy of anticipation, imagination, and hope, advancing science and improving lives.